| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GKOS | GLAUKOS Corp | Director | $4.97M | -$2.5M | -33.4% | Feb 26, 2025 |
| RVNC | Revance Therapeutics, Inc. | President & CEO, Director | $0 | Feb 4, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|